Moderna (MRNA) announced Health Canada has approved mRESVIA for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults 60 years of ...
On Oct. 1, University of Connecticut Health Center professors Lakshmi Nair and Yusuf Khan were awarded first place at the Wolff New Venture Competition for their work on Soleia Biosciences ...